Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.830
+0.360 (10.37%)
At close: Oct 19, 2026, 4:00 PM EDT
3.819
-0.011 (-0.30%)
After-hours: Oct 19, 2026, 7:53 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $681.37 million as of October 19, 2026. It is the 12,541st most valuable company in the world and the 2,506th biggest in the United States. Its market cap has decreased by 26.03% in one year.
Market Cap
681.37M
Enterprise Value
698.78M
1-Year Change
-26.03%
Global Rank
Country Rank
#2,506 United States
Category
ChartMarket Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $681.37M, a decrease of -58.13%. That is a compound annual growth rate of -19.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 681.37M | 10.91% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 645.72M |
| Design Therapeutics | 645.22M |
| Gyre Therapeutics | 644.69M |
| Aura Biosciences | 632.60M |
| Attovia Therapeutics | 626.79M |
| Candel Therapeutics | 626.69M |
| Wave Life Sciences | 616.76M |
| Nuvectis Pharma | 606.02M |